Torrent Pharmaceuticals Limited (NSE: TORNTPHARM)

India flag India · Delayed Price · Currency is INR
3,363.10
+23.95 (0.72%)
Dec 3, 2024, 3:30 PM IST
56.33%
Market Cap 1.14T
Revenue (ttm) 112.24B
Net Income (ttm) 18.02B
Shares Out n/a
EPS (ttm) 53.25
PE Ratio 63.12
Forward PE n/a
Dividend n/a
Ex-Dividend Date Jun 21, 2024
Volume 397,698
Open 3,350.20
Previous Close 3,339.15
Day's Range 3,341.60 - 3,395.00
52-Week Range 2,025.70 - 3,590.70
Beta 0.25
Analysts n/a
Price Target n/a
Earnings Date Jan 27, 2025

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company... [Read more]

Sector Healthcare
Founded 1959
Employees 15,718
Stock Exchange National Stock Exchange of India
Ticker Symbol TORNTPHARM
Full Company Profile

Financial Performance

In 2023, Torrent Pharmaceuticals's revenue was 107.28 billion, an increase of 11.51% compared to the previous year's 96.20 billion. Earnings were 16.56 billion, an increase of 33.02%.

Financial Statements

News

Pharma stocks weekly roundup: Biocon leads with 9.08% gain, Torrent Pharma up 4.91%, Lupin dips 1.82%

The pharmaceutical sector experienced diverse movements during the week of November 25–29, 2024. Among the notable performers, Biocon Ltd led the gains with a significant surge of ₹30.35 (9.08%), clos...

2 days ago - Business Upturn

Torrent Pharmaceuticals market cap rises Rs 3,450 crore

Torrent Pharmaceuticals saw its stock price rise by 3.19% to Rs 3,305.00 in today’s trading session. This price surge contributed to an increase of Rs 3,450 crore in the company’s market capitalizatio...

4 days ago - Business Upturn

Torrent Pharma receives EIR from USFDA for Pithampur facility

Torrent Pharmaceuticals has announced that it has received an Establishment Inspection Report (EIR) from the USFDA for its manufacturing facility in Pithampur, Madhya Pradesh. The inspection, conducte...

11 days ago - Business Upturn

Torrent Pharma shares rise nearly 3% after receiving EIR from USFDA

Shares of Torrent Pharmaceuticals climbed 2.54% to trade at ₹3,180.65 as of 12:16 PM on November 22. The surge comes after the company announced it has received an Establishment Inspection Report (EIR...

11 days ago - Business Upturn

Torrent Pharma Block Deal: 1.04 crore shares or 3% equity worth Rs 3,230 crore change hands

Torrent Pharmaceuticals shares dropped 3.15% to ₹3,114.35 as of 9:19 am on the NSE after a significant large trade. Approximately 1.04 crore shares, equating to 3.1% of equity, exchanged hands at ₹3,1...

4 weeks ago - Business Upturn

Stock to watch today: Torrent Pharma promoter to sell up to 2.9% stake via block deal: Report

Torrent Pharmaceuticals Ltd. is likely to be in focus today as promoter entity Torrent Investments has announced plans to sell up to a 2.9% stake in the company through a block deal. This information ...

4 weeks ago - Business Upturn

Torrent Pharmaceuticals shares in focus as Q2 profit rises 17.4% to ₹453 crore

Torrent Pharmaceuticals has attracted attention after reporting a 17.4% increase in net profit for the second quarter, rising to ₹453 crore. The company’s revenue grew by 8.6%, reaching ₹2,889 crore, ...

5 weeks ago - Business Upturn

Torrent counters faulty drug claim

Torrent Pharmaceuticals Limited strongly denies allegations regarding its Shelcal 500 product, claiming the seized sample is counterfeit and not produced by them. The company has implemented anti-coun...

2 months ago - The Times of India

Torrent Pharma announces US FDA’s inspection conclusion at Madhya Pradesh facility, shares surge over 2%

Torrent Pharmaceuticals announced that the United States Food & Drug Administration (USFDA) conducted a routine GMP inspection at its formulation manufacturing facility in Pithampur, Madhya Pradesh, b...

2 months ago - Business Upturn

Torrent Pharma shares surge around 2% after USFDA inspection closure

Torrent Pharmaceuticals (TORNTPHARM) saw its shares increase by 1.96%, trading at ₹3,502.00 at 10:21 AM on the NSE. The stock’s upward movement follows the company’s announcement that its Indrad manuf...

3 months ago - Business Upturn

Torrent Pharma’s Indrad facility receives USFDA EIR with VAI Classification

Torrent Pharmaceuticals has announced that its manufacturing facility in Indrad, Gujarat, has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA), with a...

3 months ago - Business Upturn